Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
ZR75B
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7555.098
uM
inf
inf
0.9380 0.9380 0.0000 0.0155
0.0592
1.6495
ZR75B
HR+
Luminal
Nutlin 3a
MDM2
MDM2
7555.066
uM
2.310
2.17070
0.0678 0.0312 1.0363 0.2882
0.9823
1.7081
ZR75B
HR+
Luminal
PD184352
MEK
MAPK
11939.155
uM
inf
inf
0.8123 0.8123 0.0000 0.0872
0.1864
1.6625
ZR75B
HR+
Luminal
Cetuximab
EGFR
ErbB
9997.026
uM
inf
inf
0.9578 0.9578 0.0000 -0.0328
-0.7332
1.1348
ZR75B
HR+
Luminal
Trametinib
MEK
MAPK
9997.024
uM
inf
999.97430
0.6471 -0.1387 0.2260 0.1193
0.5969
0.9704
ZR75B
HR+
Luminal
Bortezomib
Proteasome
Proteasome
7555.074
uM
0.16362
0.33589
-0.4568 -0.4040 0.8234 0.6783
0.9802
1.6682
ZR75B
HR+
Luminal
SB-3CT
MMP2/9
MMP
11939.144
uM
29.41950
23.32080
0.3378 0.3372 4.8296 0.1011
0.9481
1.6446
ZR75B
HR+
Luminal
PD184352
MEK
MAPK
11939.155
uM
inf
inf
0.8123 0.8123 0.0000 0.0872
0.1864
1.6625
ZR75B
HR+
Luminal
Baicalein
Lipoxygenase
Metabolism
7555.073
uM
62.88950
38.68310
0.3348 0.2333 1.2931 0.1098
0.9813
1.6372
ZR75B
HR+
Luminal
Trastuzumab
HER2
ErbB
9997.026
uM
10.14060
9.03470
0.8100 0.2193 4.9983 -0.0116
0.7236
1.1348
ZR75B
HR+
Luminal
Gefitinib
EGFR
ErbB
9997.049
uM
inf
inf
0.7909 0.7909 0.0000 0.0483
0.3558
1.1423
ZR75B
HR+
Luminal
Carboplatin
DNA cross-linker
DNA cross-linker
9997.011
uM
392.17980
716.46410
-0.5311 -1.0000 1.8231 0.1305
0.9710
1.0551
ZR75B
HR+
Luminal
Etoposide
TOP2
TOP
7555.074
uM
1.32870
4.60090
-0.0739 -0.2956 0.3739 0.4692
0.9938
1.6682
ZR75B
HR+
Luminal
5-DFUR
TYMS
TYMS
11939.143
uM
9.44420
7.37240
0.0351 0.0799 0.7026 0.4587
0.9862
1.7414
ZR75B
HR+
Luminal
Geldanamycin
HSP90
HSP90
9972.012
uM
0.03571
0.03964
-0.1050 -0.0756 1.3466 0.6483
0.9968
1.1986
ZR75B
HR+
Luminal
ICRF-193
TOP2
TOP
11939.157
uM
0.39731
0.10744
0.4014 0.4355 1.5658 0.2860
0.9681
1.5908
ZR75B
HR+
Luminal
Methylglyoxal
13525.184
uM
609.46450
1000.00000
-0.8388 -0.3641 1.1049 0.3628
0.8593
1.7478
ZR75B
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
11939.154
uM
inf
inf
0.8647 0.8647 0.0000 0.0937
0.0531
1.7246
ZR75B
HR+
Luminal
Ribavirin
15405.211
uM
inf
inf
0.4764 0.4764 0.0000 0.1513
0.5573
1.5333
ZR75B
HR+
Luminal
Afatinib
EGFR/HER2
ErbB
11939.158
uM
3.02660
4.45570
-0.8910 -0.9000 2.6622 0.4909
0.9719
1.7251
ZR75B
HR+
Luminal
XRP44X
ELK3
MAPK
11939.157
uM
1.36460
1.02480
0.2317 0.2281 2.1272 0.3166
0.9749
1.5908
ZR75B
HR+
Luminal
(Z)-4-Hydroxytamoxifen
ESR1
9972.019
uM
16.51190
102.41180
-0.1602 -1.0000 0.6020 0.2248
0.9936
1.0654
ZR75B
HR+
Luminal
JNK-IN-5A
JNK
JNK
11939.144
uM
2.91330
2.00940
0.4784 0.4219 5.0000 0.1912
0.8989
1.6446
ZR75B
HR+
Luminal
Docetaxel
TUBB
TUBB
9972.002
uM
0.00317
0.00240
0.2383 0.2593 2.6193 0.4707
0.9839
1.0054
ZR75B
HR+
Luminal
Ibandronate
FDPS
11939.143
uM
120.22610
103.64040
0.1901 0.1895 3.2097 0.1786
0.9863
1.7414